Regulatory Guidance for Pharmaceutical Nanotechnology

Nanotechnology represents a platform for developing revolutionary changes and improvements to many different aspects of pharmaceutical manufacturing. Also, the rate of nanotechnology discovery is proceeding more rapidly than practical applications can be found. Nanotechnology offers potential in pharmaceuticals for improving drug delivery systems, medical imaging, diagnosis, cancer therapy, and regenerative medicine. Although there is no international regulation or legislation specifically for nanomedicine, it is agreed worldwide that considerably more attention should be paid to the quality, safety, and efficacy of nanotechnology-based drugs. The US FDA and the European Medicines Agency have provided several regulatory guidelines for the development of nanomedicines.

  • Enable major investments and advances in basic sciences to translate faster into products to benefit consumer
  • Protect consumers by applying best possible science to support regulatory activities and decision-making
  • Keep pace with and fully utilize advances in innovation
  • Facilitating development of innovative products that benefit consumers and patients
  • Regulatory aspects towards approval of nanomedicine

Related Conference of Regulatory Guidance for Pharmaceutical Nanotechnology

November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

Regulatory Guidance for Pharmaceutical Nanotechnology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in